Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. (TCRT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · TCRT · as of Sep 30, 2025
Ownership Breakdown
24
Institutional Holders
▼ 3 vs Q2
$158,311
Total Inst. Value
▼ $186,272 vs Q2
2.44M
Shares Outstanding
freeFloat 78.13%
65,224
13F Shares Held
▼ 5,828 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
TCRT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 21.4K | 1.27% | 1.27% | $51.46M | Nov 12, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 21.0K | 1.25% | 1.25% | $51.17M | Nov 7, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 15.8K | 94.20% | 94.20% | $38.54M | Nov 12, 2025 | ▼ 155 |
MORGAN STANLEY pharmaceutical preparations | 1.7K | 10.05% | 10.05% | $4.06M | May 27, 2026 | ▼ 114 |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 1.6K | 9.74% | 9.74% | $3.94M | Nov 14, 2025 | ▲ 660 |
UBS GROUP AG pharmaceutical preparations | 1.5K | 9.14% | 9.14% | $3.69M | Nov 13, 2025 | ▼ 5.3K |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 1.2K | 6.95% | 6.95% | $2.81M | Nov 14, 2025 | ▲ 470 |
CIBC PRIVATE WEALTH GROUP, LLC pharmaceutical preparations | 300 | 1.79% | 1.79% | $723,000 | Nov 24, 2025 | — held |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 183 | 1.09% | 1.09% | $441,000 | Nov 13, 2025 | — held |
RONALD BLUE TRUST, INC. pharmaceutical preparations | 135 | 0.81% | 0.81% | $325,000 | Oct 16, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
3
Increased
+1.1K shares3
New Positions
first time holders6
Decreased
−6.6K shares6
Sold Out
fully exitedNet shares change (top 50)
5.5K
+1.1K / −6.6K
Net new holders
-6
3 new / 6 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
TCRT insider trading · insider activity
Source: SEC Form 4
3
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Weis Holger Chief Executive Officer | May 22, 2026 | Award | 3,700 | $2.37 | $8.8K | 4.9K | Form 4 ↗ |
Vieser Jaime director | Apr 29, 2026 | Award | 6,515 | $2.59 | $16.9K | 38.9K | Form 4 ↗ |
Postma Robert W director | Apr 29, 2026 | Award | 6,274 | $2.59 | $16.2K | 50.1K | Form 4 ↗ |
Jerman Michael Allen director | Apr 29, 2026 | Award | 6,032 | $2.59 | $15.6K | 15.6K | Form 4 ↗ |
Jerman Michael Allen director | Jan 12, 2026 | Award | 5,406 | $2.89 | $15.6K | 9.6K | Form 4 ↗ |
Postma Robert W director | Jan 12, 2026 | Award | 5,622 | $2.89 | $16.2K | 43.9K | Form 4 ↗ |
Vieser Jaime director | Jan 12, 2026 | Award | 5,839 | $2.89 | $16.9K | 32.3K | Form 4 ↗ |
Vieser Jaime director | Nov 21, 2025 | Award | 5,340 | $3.16 | $16.9K | 26.5K | Form 4 ↗ |
Postma Robert W director | Nov 21, 2025 | Award | 5,142 | $3.16 | $16.2K | 38.3K | Form 4 ↗ |
Jerman Michael Allen director | Nov 21, 2025 | Award | 4,183 | $3.16 | $13.2K | 4.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Alaunos Therapeutics, Inc. (TCRT) is primarily owned by institutional investors, who hold approximately 2.7% of total shares outstanding. Company insiders own approximately 21.87%, while retail and public investors account for the remaining 75.46%.
The largest institutional shareholder of Alaunos Therapeutics, Inc. is BLACKROCK, INC., holding approximately 21,353 shares — equal to 1.27% of outstanding shares — as of September 30, 2025.
A total of 24 institutional investors currently hold TCRT stock, with a combined institutional value of approximately $158,311 as of the most recent 13F filing period.
Frequently asked questions
TCRT ownershipAlaunos Therapeutics, Inc. (TCRT) is primarily owned by institutional investors, who hold approximately 2.7% of shares. The largest shareholder is BLACKROCK, INC. with a 1.27% stake. Company insiders hold 21.87%. Data sourced from SEC Form 13F as of September 30, 2025.